Monday, March 12, 2018 10:52:10 AM
At the H.C. Wainwright 2nd Annual NASH Investor Conference (March 19 in New York), Dr. Marshall will present a NASH-focused presentation beginning at 3:40 p.m. again appears to be more of a private event.
The next one, however, (two days later on the 21st) states we will get transcripts via CNAT's website:
At the Oppenheimer Healthcare Conference (March 20-21 in New York), Dr. Mento and Dr. Marshall will meet with investment professionals and will provide an overview and update presentation beginning at 10:20 a.m. ET on Wednesday, March 21. An audio webcast and copy of the Oppenheimer conference presentation will be available in the Investors section of the company’s website at www.conatuspharma.com.
Conatus Pharmaceuticals to Highlight Anticipated Clinical Data Readouts at Upcoming Investor Conferences
FEATURED POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • Mar 27, 2024 10:52 AM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM